Similar Papers

Paper Title
Journal
Date
Author
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies
Andi K Cani ... Rajesh C Rao
Modern Pathology | VOL. 29
Andi K Cani, et. al.Andi K Cani ... Rajesh C Rao
01 Jul 2016
From Microarray to Bedside: Targeting NF-κB for Therapy of Lymphomas
Arnold B Rabson ... David Weissmann
Clinical Cancer Research | VOL. 11
Arnold B Rabson, et. al.Arnold B Rabson ... David Weissmann
01 Jan 2004
Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A.
Shanshan Sun ... Hui Wang
Technology in Cancer Research & Treatment | VOL. 18
Shanshan Sun, et. al.Shanshan Sun ... Hui Wang
01 Jan 2019
Comparison of pathological features and prognosis between orbital and systemic diffuse large B cell lymphoma
...
Chinese Journal of Experimental Ophthalmology | VOL. 32
, et. al. ...
10 Oct 2014
View more papers

More From: Blood

Paper Title
Journal
Date
Author
DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis.
Sebastiaan N J Laan ... Iris Van Moort
Blood | VOL. -
Sebastiaan N J Laan, et. al.Sebastiaan N J Laan ... Iris Van Moort
24 Jan 2025
The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment.
Sameem M Abedin ... Laura C Michaelis
Blood | VOL. -
Sameem M Abedin, et. al.Sameem M Abedin ... Laura C Michaelis
24 Jan 2025
One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them.
Ainsley V.C Knox ... Neil Romberg
Blood | VOL. -
Ainsley V.C Knox, et. al.Ainsley V.C Knox ... Neil Romberg
24 Jan 2025
VenEx precisely predicts ven-aza response.
Pamela S Becker
Blood | VOL. 145
Pamela S BeckerPamela S Becker
23 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.